Study results showing that benzoyl peroxide 3% plus clindamycin 1% demonstrated significant acne lesion reduction was the most read-article of the week on Healio.com/Dermatology.
Other widely read articles included research presented at the American Society for Dermatologic Surgery on the effects of repeated Botox treatment on static glabellar lines and an analysis showing that dermatologists led research in most noninvasive cosmetic procedures:
Benzoyl peroxide 3% plus clindamycin 1% demonstrated significant acne lesion reduction
Stiefel announced in a press release results of a German study demonstrating that treatment with its Duac 3% gel led to fewer inflammatory and noninflammatory lesions from baseline at all study time points in patients with mild-to-moderate acne vulgaris, when compared to treatment with Skinoren cream.
“We are pleased to share the findings from this study, which add to the body of evidence supporting the use of benzoyl peroxide 3% + clindamycin 1% in patients with mild and moderate acne,” Karen Langfeld, PhD, global medical head, Stiefel, told Healio.com/Dermatology. Read more
Repeated Botox treatments led to progressive improvement in static glabellar lines
CHICAGO — Patients repeatedly treated with Botox over the long term displayed a progressive improvement in static glabellar lines, according to research presented at the American Society for Dermatologic Surgery annual meeting.
“This study amplifies the positive effects of injectable neuromodulators in long-term use in the glabella," Alastair Carruthers, FRCPC, told Healio.com. Read more
Dermatologists led research in most noninvasive cosmetic procedures, ASDS analysis finds
CHICAGO — Dermatologists led as researchers in most categories in an analysis of published studies focusing on noninvasive or minimally invasive cosmetic procedures, according to results presented at the American Society for Dermatologic Surgery annual meeting.
Omar A. Ibrahimi
Omar A. Ibrahimi, MD, PhD, presented the results of a study funded by ASDS at the meeting’s opening session. Read more
AbbVie launches hidradenitis suppurativa global awareness campaign
AbbVie has launched a new global campaign to increase awareness and support for people who have hidradenitis suppurativa.
The FDA approved AbbVie’s Humira (adalimumab) for treating adults with moderate to severe HS in September. Read more
BioPharmX presents early research results of hydrophilic topical gel for acne treatment
BioPharmX Corp. has announced that it will be presenting data on its investigational drug, BPX-01, at the Skin Disease Education Foundation’s 11th Annual Women’s & Pediatric Dermatology Seminar, according to a press release.
BPX-01 is a hydrophilic topical gel designed to deliver antibiotic into the skin’s target anatomy where acne develops, according to the release. Read more